A Safety and Efficacy Study of Ustekinumab in Patients With Plaque Psoriasis Who Have Had an Inadequate Response to Methotrexate

NCT01059773 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

490

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: Ustekinumab
DRUG: Methotrexate

Sponsor

Janssen-Cilag International NV